Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Small bowel carcinoma mimicking a relapse of Crohn's disease: a case series.

Baars JE, Thijs JC, Bac DJ, Ter Borg PC, Kuipers EJ, van der Woude CJ.

J Crohns Colitis. 2011 Apr;5(2):152-6. doi: 10.1016/j.crohns.2010.10.008. Epub 2010 Dec 10.

PMID:
21453885
2.

The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis.

Kuiper EM, Hansen BE, Lesterhuis W, Robijn RJ, Thijs JC, Engels LG, Koek GH, Aparicio MN, Kerbert-Dreteler MJ, van Buuren HR; Dutch PBC study group.

Clin Res Hepatol Gastroenterol. 2011 Jan;35(1):29-33. doi: 10.1016/j.gcb.2010.07.018.

PMID:
20810227
3.

[The Nobel Prize in Physiology or Medicine for 2005 for the discovery of the stomach bacterium Helicobacter pylori].

Kleibeuker JH, Thijs JC.

Ned Tijdschr Geneeskd. 2005 Dec 31;149(53):2955-7. Dutch.

PMID:
16425846
4.

Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.

Klok RM, Arents NL, de Vries R, Thijs JC, Brouwers JR, Kleibeuker JH, Postma MJ.

Clin Ther. 2005 Oct;27(10):1647-57.

PMID:
16330302
5.

The management of univestigated dyspepsia in primary care.

Thijs JC, Kleibeuker JH.

Minerva Gastroenterol Dietol. 2005 Sep;51(3):213-24. Review.

PMID:
16280963
6.

Functional dyspepsia.

Kleibeuker JH, Thijs JC.

Curr Opin Gastroenterol. 2004 Nov;20(6):546-50.

PMID:
15703680
7.

Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori.

Gerrits MM, van der Wouden EJ, Bax DA, van Zwet AA, van Vliet AH, de Jong A, Kusters JG, Thijs JC, Kuipers EJ.

J Med Microbiol. 2004 Nov;53(Pt 11):1123-8.

PMID:
15496391
8.

Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period.

Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH.

Eur J Gastroenterol Hepatol. 2004 Aug;16(8):779-83.

PMID:
15256980
9.

Dyspepsia management in primary care.

Thijs JC, Arents NL, van Zwet AA, Kleibeuker JH.

Scand J Gastroenterol Suppl. 2003;(239):44-50. Review.

PMID:
14743883
10.

Approach to treatment of dyspepsia in primary care: a randomized trial comparing "test-and-treat" with prompt endoscopy.

Arents NL, Thijs JC, van Zwet AA, Oudkerk Pool M, Gotz JM, van de Werf GT, Reenders K, Sluiter WJ, Kleibeuker JH.

Arch Intern Med. 2003 Jul 14;163(13):1606-12.

PMID:
12860586
11.

A rational approach to uninvestigated dyspepsia in primary care: review of the literature.

Arents NL, Thijs JC, Kleibeuker JH.

Postgrad Med J. 2002 Dec;78(926):707-16. Review.

12.

Mechanism and clinical significance of metronidazole resistance in Helicobacter pylori.

van der Wouden EJ, Thijs JC, Kusters JG, van Zwet AA, Kleibeuker JH.

Scand J Gastroenterol Suppl. 2001;(234):10-4. Review.

PMID:
11768554
13.

Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease.

van der Wouden EJ, Thijs JC, van Zwet AA, Kleibeuker JH.

Eur J Gastroenterol Hepatol. 2001 Oct;13(10):1235-9.

PMID:
11711782
14.

The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease.

Arents NL, van Zwet AA, Thijs JC, Kooistra-Smid AM, van Slochteren KR, Degener JE, Kleibeuker JH, van Doorn LJ.

Am J Gastroenterol. 2001 Sep;96(9):2603-8.

PMID:
11569682
15.

Implications of the simultaneous presence of metronidazole-susceptible and -resistant Helicobacter pylori colonies within a single biopsy specimen.

Arents NL, Smeets LC, van Zwet AA, Thijs JC, van der Wouden EJ, de Jong A, Degener JE, Kusters JG.

Eur J Clin Microbiol Infect Dis. 2001 Jun;20(6):418-20.

PMID:
11476444
16.

The accuracy of the Helicobacter pylori stool antigen test in diagnosing H. pylori in treated and untreated patients.

Arents NL, van Zwet AA, Thijs JC, de Jong A, Pool MO, Kleibeuker JH.

Eur J Gastroenterol Hepatol. 2001 Apr;13(4):383-6.

PMID:
11338066
17.

[Decreasing prevalence of Helicobacter pylori: a consequence of treatment of gastroduodenal ulcers].

van der Weerd NC, Cats A, Thijs JC, Festen HP, Meuwissen SG, Kuipers EJ.

Ned Tijdschr Geneeskd. 2000 Jul 15;144(29):1385-8. Review. Dutch.

PMID:
10923145
18.

Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.

Schenk BE, Kuipers EJ, Nelis GF, Bloemena E, Thijs JC, Snel P, Luckers AE, Klinkenberg-Knol EC, Festen HP, Viergever PP, Lindeman J, Meuwissen SG.

Gut. 2000 May;46(5):615-21.

19.

Review article: nitroimidazole resistance in Helicobacter pylori.

Van Der Wouden EJ, Thijs JC, Van Zwet AA, Kleibeuker JH.

Aliment Pharmacol Ther. 2000 Jan;14(1):7-14. Review.

20.

Metronidazole susceptibility in Helicobacter pylori.

Van der Wouden EJ, Thijs JC, Van Zwet AA.

Gastroenterology. 1999 Oct;117(4):1032-3. No abstract available.

PMID:
10576979
21.

Reliability of biopsy-based diagnostic tests for Helicobacter pylori after treatment aimed at its eradication.

van der Wouden EJ, Thijs JC, van Zwet AA, Oey HB, Kleibeuker JH.

Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1255-8.

PMID:
10563536
22.

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis.

van der Wouden EJ, Thijs JC, van Zwet AA, Sluiter WJ, Kleibeuker JH.

Am J Gastroenterol. 1999 Jul;94(7):1751-9.

PMID:
10406231
23.

Subpopulations of Helicobacter pylori are responsible for discrepancies in the outcome of nitroimidazole susceptibility testing.

van der Wouden EJ, de Jong A, Thijs JC, Kleibeuker JH, van Zwet AA.

Antimicrob Agents Chemother. 1999 Jun;43(6):1484-6.

24.

The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.

Van der Wouden EJ, Thijs JC, Zwet AA, Kooy A, Kleibeuker JH.

Aliment Pharmacol Ther. 1999 Mar;13(3):297-302.

25.

Stable amoxicillin resistance in Helicobacter pylori.

van Zwet AA, Vandenbroucke-Grauls CM, Thijs JC, van der Wouden EJ, Gerrits MM, Kusters JG.

Lancet. 1998 Nov 14;352(9140):1595. No abstract available. Erratum in: Lancet 1999 Jan 9;353(9147):154. Vandenbrouke-Grauls CM [corrected to Vandenbroucke-Grauls CM].

PMID:
9843107
27.

Low cure rate of Helicobacter pylori infection with omeprazole and furazolidone dual therapy for one week.

Van Zwet AA, Thijs JC, van der Wouden EJ, Kooy A.

Aliment Pharmacol Ther. 1997 Jun;11(3):533-5.

28.

One-week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance.

Thijs JC, Van Zwet AA, Thijs WJ, Van der Wouden EJ, Kooy A.

Aliment Pharmacol Ther. 1997 Apr;11(2):305-9.

29.

Evaluation of eight enzyme immunoassays for detection of immunoglobulin G against Helicobacter pylori.

Meijer BC, Thijs JC, Kleibeuker JH, van Zwet AA, Berrelkamp RJ.

J Clin Microbiol. 1997 Jan;35(1):292-4.

30.

Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in The Netherlands.

van Zwet AA, de Boer WA, Schneeberger PM, Weel J, Jansz AR, Thijs JC.

Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):861-4.

PMID:
8997557
31.

Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard.

Thijs JC, van Zwet AA, Thijs WJ, Oey HB, Karrenbeld A, Stellaard F, Luijt DS, Meyer BC, Kleibeuker JH.

Am J Gastroenterol. 1996 Oct;91(10):2125-9.

PMID:
8855734
32.

Practical diagnosis of Helicobacter pylori infection.

van Zwet AA, Thijs JC, Roosendaal R, Kuipers EJ, Peña S, de Graaff J.

Eur J Gastroenterol Hepatol. 1996 May;8(5):501-7. Review.

PMID:
8804881
33.
34.

Evaluation of clinical and home performance of the 13C-urea breath test for the detection of Helicobacter pylori.

Thijs WJ, Thijs JC, Kleibeuker JH, Elzinga H, Stellaard F.

Eur J Gastroenterol Hepatol. 1995 Jul;7(7):603-7.

PMID:
8590153
35.

Treatment of Helicobacter pylori infections.

Thijs JC, Kuipers EJ, van Zwet AA, Pena AS, de Graaff J.

QJM. 1995 Jun;88(6):369-89. Review.

PMID:
7648229
36.

The prevalence of Helicobacter pylori in peptic ulcer disease.

Kuipers EJ, Thijs JC, Festen HP.

Aliment Pharmacol Ther. 1995;9 Suppl 2:59-69. Review.

PMID:
8547530
38.

Use of PCR with feces for detection of Helicobacter pylori infections in patients.

van Zwet AA, Thijs JC, Kooistra-Smid AM, Schirm J, Snijder JA.

J Clin Microbiol. 1994 May;32(5):1346-8.

39.

In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori.

van Zwet AA, Thijs JC, Schievink-de Vries W, Schiphuis J, Snijder JA.

Antimicrob Agents Chemother. 1994 Feb;38(2):360-2.

40.

Short report: clarithromycin, an alternative to metronidazole in the triple therapy of Helicobacter pylori infection.

Thijs JC, Van Zwet AA, Moolenaar W, Oom JA, De Korte H, Runhaar EA.

Aliment Pharmacol Ther. 1994 Feb;8(1):131-4.

PMID:
8186339
41.

Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori.

Thijs JC, Van Zwet AA, Oey HB.

Scand J Gastroenterol. 1993 Nov;28(11):934-8.

PMID:
8284626
42.

Sensitivity of culture compared with that of polymerase chain reaction for detection of Helicobacter pylori from antral biopsy samples.

van Zwet AA, Thijs JC, Kooistra-Smid AM, Schirm J, Snijder JA.

J Clin Microbiol. 1993 Jul;31(7):1918-20.

43.

Serological tests to monitor treatment of Helicobacter pylori.

van Zwet AA, Meyer BC, Berrelkamp RJ, Thijs JC.

Lancet. 1992 Jul 4;340(8810):51. No abstract available.

PMID:
1351623
44.
45.

Postinfantile giant cell hepatitis in a patient with multiple autoimmune features.

Thijs JC, Bosma A, Henzen-Logmans SC, Meuwissen SG.

Am J Gastroenterol. 1985 Apr;80(4):294-7.

PMID:
3985001
46.

[Is endoscopy of the proximal digestive system at the request of the general practitioner useful?].

Lückers AE, Thijs JC, Westerveld BD, Festen HP, Meuwissen SG.

Ned Tijdschr Geneeskd. 1985 Jan 19;129(3):117-9. Dutch. No abstract available.

PMID:
3982525
47.

Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels.

Festen HP, Thijs JC, Lamers CB, Jansen JM, Pals G, Frants RR, Défize J, Meuwissen SG.

Gastroenterology. 1984 Nov;87(5):1030-4.

PMID:
6479529
48.

[Idiopathic edema is not idiopathic].

Westerman RF, Thijs JC, Tuynman HA.

Ned Tijdschr Geneeskd. 1984 Jun 2;128(22):1033-5. Dutch. No abstract available.

PMID:
6377097
49.

A family infected with hepatitis B and with concurrently circulating HBsAg and heterotypic anti-HBs.

Thijs JC, van Bergeijk L, Heijtink RA, Douwes AC, Meuwissen SG.

Hepatogastroenterology. 1984 Apr;31(2):69-71.

PMID:
6724498
50.

Spontaneous rupture of the spleen complicating portal hypertension.

Thijs JC, Schneider AJ, van Kordelaar JM.

Intensive Care Med. 1983;9(5):299-300.

PMID:
6619401

Supplemental Content

Loading ...
Support Center